HRT Financial’s Lunai Bioworks LNAI Stock Holding History

HRT Financial’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-178	Closed	-$45K	–	2959
2023 Q4	$45K	Buy	+178	New	+$48.8K	﹤0.01%	1966
2023 Q2	–	Sell	-484	Closed	-$35K	–	3134
2023 Q1	$35K	Buy	+484	New	+$42.6K	﹤0.01%	2148
2021 Q3	–	Sell	-513	Closed	-$204K	–	3681
2021 Q2	$204K	Sell	513 -520	-50%	-$169K	﹤0.01%	2375
2021 Q1	$292K	Buy	+1,033	New	+$304K	﹤0.01%	2113
2020 Q4	–	Sell	-525	Closed	-$150K	–	2351
2020 Q3	$150K	Buy	+525	New	+$165K	﹤0.01%	1443

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's LNAI Position: Q1 2024 in Review

HRT Financial sold out of Lunai Bioworks (LNAI) in Q1 2024, closing a stake of 178 shares — an estimated $45K sold.

HRT Financial first reported a position in LNAI in Q3 2020 and held it in 5 quarters. The position peaked at $292K in Q1 2021. 41 funds tracked by Wall St. Rank hold LNAI as of Q1 2024.

HRT Financial reported no remaining Lunai Bioworks position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 178 Lunai Bioworks shares in Q1 2024, an estimated $45K.
HRT Financial first reported a position in Lunai Bioworks in Q3 2020 and held it in 5 quarters.
HRT Financial's Lunai Bioworks position peaked at $292K in Q1 2021.
41 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.